|
Diabetes Care, Vol 22, Issue 7 1171-1175, Copyright © 1999 by American Diabetes Association
Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients
SK Jain, R McVie, R Jackson, SN Levine and G Lim
Department of Pediatrics, Louisiana State University Medical Center, Shreveport, USA.
OBJECTIVE: This study was undertaken to examine the effect of ketosis on
plasma lipid peroxidation levels in diabetic patients. RESEARCH DESIGN AND
METHODS: Plasma levels of lipid peroxidation products (malondialdehyde) and
ketone bodies (acetoacetate and beta-hydroxybutyrate) were determined in
diabetic patients (n = 70) and age-matched normal volunteers (n = 25).
Diabetic patients with total ketone body levels > 1.0 mmol/l were
considered hyperketonemic, and those with levels < or = 1.0 mmol/l were
considered normoketonemic. RESULTS: After normalization versus total
lipids, levels of lipid peroxidation were significantly higher in the
plasma of hyperketonemic diabetic patients (P < 0.05), but not in
normoketonemic diabetic patients, compared with age-matched normal
volunteers. In addition, low ketonemia was associated with lower lipid
peroxidation levels when lipid peroxidation and ketonemia were determined
in the same patient (n = 7) at two different clinic visits. CONCLUSIONS:
This study demonstrated an association between hyperketonemia and increased
lipid peroxidation levels in diabetic patients, which suggests that ketosis
is a risk factor in the elevated lipid peroxidation levels associated with
diabetes. Further investigation is needed to determine whether antioxidant
supplementation can be particularly beneficial in reducing lipid
peroxidation and complications in type 1 diabetic patients who frequently
encounter ketosis.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. P. Langford, T. B. Redens, N. R. Harris, S. Lee, S. K. Jain, S. Reddy, and R. McVie
Plasma Levels of Cell-Free Apoptotic DNA Ladders and Gamma-Glutamyltranspeptidase (GGT) in Diabetic Children
Experimental Biology and Medicine,
October 1, 2007;
232(9):
1160 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pelletier and L. Coderre
Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1325 - E1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Stentz, G. E. Umpierrez, R. Cuervo, and A. E. Kitabchi
Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic Crises
Diabetes,
August 1, 2004;
53(8):
2079 - 2086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Jain, K. Kannan, G. Lim, J. Matthews-Greer, R. McVie, and J. A. Bocchini Jr
Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 Monocytes
Diabetes Care,
July 1, 2003;
26(7):
2139 - 2143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Jain, K. Kannan, G. Lim, R. McVie, and J. A. Bocchini Jr.
Hyperketonemia Increases Tumor Necrosis Factor-{alpha} Secretion in Cultured U937 Monocytes and Type 1 Diabetic Patients and Is Apparently Mediated by Oxidative Stress and cAMP Deficiency
Diabetes,
July 1, 2002;
51(7):
2287 - 2293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Desco, M. Asensi, R. Marquez, J. Martinez-Valls, M. Vento, F. V. Pallardo, J. Sastre, and J. Vina
Xanthine Oxidase Is Involved in Free Radical Production in Type 1 Diabetes: Protection by Allopurinol
Diabetes,
April 1, 2002;
51(4):
1118 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. MELHEM, P. A. CRAVEN, and F. R. DERUBERTIS
Effects of Dietary Supplementation of {{alpha}}-Lipoic Acid on Early Glomerular Injury in Diabetes Mellitus
J. Am. Soc. Nephrol.,
January 1, 2001;
12(1):
124 - 133.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|